文献速递肥胖与代谢综合征糖尿病

代谢健康型肥胖真的健康吗?381,363名英国生物银行参与者的前瞻性队列研究

Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants.
PubMed 文献 · Diabetologia · 2021-06-10

该研究基于英国生物银行381,363名参与者、中位随访11.2年的前瞻性队列,发现代谢健康型肥胖(MHO)与非肥胖者相比心力衰竭和呼吸系统疾病风险升高,与代谢健康非肥胖者相比糖尿病、ASCVD、心衰、呼吸系统疾病及全因死亡风险均升高。结论建议所有肥胖者均应进行体重管理,并避免使用「MHO」这一误导性术语。

要点

  • MHO与代谢健康非肥胖者相比,糖尿病风险HR 4.32,ASCVD风险HR 1.18,心衰风险HR 1.76。
  • MHO与非肥胖者相比心衰风险HR 1.60,呼吸系统疾病风险HR 1.20,ASCVD风险未升高。
  • 所有肥胖者无论代谢状态均应推荐体重管理,避免使用「代谢健康型肥胖」术语。

核心结论

  • 代谢健康型肥胖并非真正健康,与多种肥胖相关结局风险升高相关。
  • 应建议所有肥胖者进行体重管理,不论其代谢状态如何。
  • 「代谢健康型肥胖」术语具有误导性,应避免使用,并需探索不同的风险分层策略。

研究设计与样本

  • 基于英国生物银行的前瞻性队列研究,纳入381,363名参与者,中位随访11.2年。
  • MHO定义为BMI≥30 kg/m2且满足六项代谢健康标准中至少四项。

主要发现

  • 与非肥胖者相比,MHO者心衰发生率HR 1.60(95%CI 1.45,1.75),呼吸系统疾病HR 1.20(95%CI 1.16,1.25),ASCVD未升高。
  • 与非肥胖者相比,MHO者致命结局关联较弱,仅全因死亡HR 1.12(95%CI 1.04,1.21)和心衰死亡HR 1.44(95%CI 1.09,1.89)显著。
  • 与代谢健康非肥胖者相比,MHO者糖尿病HR 4.32(95%CI 3.83,4.89),ASCVD HR 1.18(95%CI 1.10,1.27),心衰HR 1.76(95%CI 1.61,1.92),呼吸系统疾病HR 1.28(95%CI 1.24,1.33),全因死亡HR 1.22(95%CI 1.14,1.31)。
  • 5年landmark分析结果相似。

关键数值与推荐

  • MHO定义:BMI≥30 kg/m2且至少满足六项代谢健康标准中的四项。
  • 结局包括新发糖尿病、新发及致命动脉粥样硬化性心血管疾病(ASCVD)、心力衰竭(HF)和呼吸系统疾病。

临床怎么用

  • 对所有肥胖者均应推荐体重管理,无论代谢状态是否健康。
  • 避免使用「代谢健康型肥胖」术语,因其可能误导风险评估。
  • 需探索不同的风险分层策略以识别肥胖相关并发症高风险个体。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: People with obesity and a normal metabolic profile are sometimes referred to as having 'metabolically healthy obesity' (MHO). However, whether this group of individuals are actually 'healthy' is uncertain. This study aims to examine the associations of MHO with a wide range of obesity-related outcomes. METHODS: This is a population-based prospective cohort study of 381,363 UK Biobank participants with a median follow-up of 11.2 years. MHO was defined as having a BMI ≥ 30 kg/m2 and at least four of the six metabolically healthy criteria. Outcomes included incident diabetes and incident and fatal atherosclerotic CVD (ASCVD), heart failure (HF) and respiratory diseases. RESULTS: Compared with people who were not obese at baseline, those with MHO had higher incident HF (HR 1.60; 95% CI 1.45, 1.75) and respiratory disease (HR 1.20; 95% CI 1.16, 1.25) rates, but not higher ASCVD. The associations of MHO were generally weaker for fatal outcomes and only significant for all-cause (HR 1.12; 95% CI 1.04, 1.21) and HF mortality rates (HR 1.44; 95% CI 1.09, 1.89). However, when compared with people who were metabolically healthy without obesity, participants with MHO had higher rates of incident diabetes (HR 4.32; 95% CI 3.83, 4.89), ASCVD (HR 1.18; 95% CI 1.10, 1.27), HF (HR 1.76; 95% CI 1.61, 1.92), respiratory diseases (HR 1.28; 95% CI 1.24, 1.33) and all-cause mortality (HR 1.22; 95% CI 1.14, 1.31). The results with a 5 year landmark analysis were similar. CONCLUSIONS/INTERPRETATION: Weight management should be recommended to all people with obesity, irrespective of their metabolic status, to lower risk of diabetes, ASCVD, HF and respiratory diseases. The term 'MHO' should be avoided as it is misleading and different strategies for risk stratification should be explored.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Zhou Z, Macpherson J, Gray SR, et al. Are people with metabolically healthy obesity really healthy? A prospective cohort study of 381,363 UK Biobank participants. Diabetologia. 2021. PMID: 34109441. doi:10.1007/s00125-021-05484-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。